Plan of the Day Radiotherapy
Cervix Cancer
About this trial
This is an interventional treatment trial for Cervix Cancer
Eligibility Criteria
Inclusion Criteria: Histologically confirmed cervical cancer eligible for definitve radiochemotherapy FIGO stage IB1-IVa Over 18 years Speaks and understands Norwegian or English. ECOG 0-2 Histology: Squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma Ability to understand and fill in patient questionnaires, and willing to sign a written informed consent Large movers (LM), fundus movement ≥2,5 cm. Exclusion Criteria: Evidence of distant metastasis. Suspicious paraaortic lymphnodes below the renal vessels is allowed if they are covered by the radiation field Patients with previous surgery for their cervical cancer Uncontrolled intercurrent somatic illness. Psychiatric illness /social situations limiting study compliance Prior radiotherapy to the pelvis Patients who are pregnant or breastfeeding is excluded due to risk of teratogenic and abortifacient effects of radiotherapy and cisplatin, and the potential risk of adverse effect of nursing infants Patients under current treatment for other invasive s except non-melanoma skin cancers Nephrostomy Patients with inflammatory bowel disease
Sites / Locations
- Oslo University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention arm
Control arm